Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wu

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2021
Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck CancerGrete May Engeseth, Renjie He, Dragan Mirkovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 18, 2020
Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancersGrete May Engeseth, Sonja Stieb, Abdallah Sherif Radwan Mohamed, et al.
The Laryngoscope|November 12, 2024
A Randomized Pilot Trial of Virtual Reality Surgical Planning for Head and Neck Oncologic ResectionKathryn L Nunes, Victor Jegede, Derek S Mann, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Lancet (London, England)|October 12, 2015
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialDiamant Thaçi, Eric L Simpson, Lisa A Beck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patientsLaszlo G Radvanyi, Chantale Bernatchez, Minying Zhang, et al.
Lancet (London, England)|September 15, 2022
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trialSungjune Kim, Evan Wuthrick, Dukagjin Blakaj, et al.
Eclinicalmedicine|July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trialKatherine V Houser, Martin R Gaudinski, Myra Happe, et al.
Journal of the American College of Cardiology|December 13, 2025
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-USMohit K Turagam, Arash Aryana, John D Day, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2021
Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck CancerGrete May Engeseth, Renjie He, Dragan Mirkovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 18, 2020
Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancersGrete May Engeseth, Sonja Stieb, Abdallah Sherif Radwan Mohamed, et al.
The Laryngoscope|November 12, 2024
A Randomized Pilot Trial of Virtual Reality Surgical Planning for Head and Neck Oncologic ResectionKathryn L Nunes, Victor Jegede, Derek S Mann, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Lancet (London, England)|October 12, 2015
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialDiamant Thaçi, Eric L Simpson, Lisa A Beck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patientsLaszlo G Radvanyi, Chantale Bernatchez, Minying Zhang, et al.
Lancet (London, England)|September 15, 2022
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trialSungjune Kim, Evan Wuthrick, Dukagjin Blakaj, et al.
Eclinicalmedicine|July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trialKatherine V Houser, Martin R Gaudinski, Myra Happe, et al.
Journal of the American College of Cardiology|December 13, 2025
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-USMohit K Turagam, Arash Aryana, John D Day, et al.
Pageof 11